Table 7 Adherence and cost (in US$ (2005)) for most recent treatment
From: Access to artemisinin combination therapy for malaria in remote areas of Cambodia
Regime (Recommended duration) | % achieving recommended durations (n) | Median cost in US$ (range) |
|---|---|---|
Artesunate + Mefloquine (3 days) | 77% (34/44) | 0.77 (0 – 12.82) |
Artemisinin derivative + other antimalarial (7 days) | 13% (4/31) | 1.67 (0.22 – 38.90) |
Artemisinin alone* (7 days) | 28% (8/29) | 2.05 (0.38 – 26.70) |
Quinine + tetracycline (+/- other antimalarial) (7 days) | 0% (0/13) | 1.11 (0.35 – 17.3) |
Quinine (+/- other antimalarial) (7 days) | 13% (3/24) | 0.66 (0 – 11.10) |
Chloroquine (+/- other antimalarial) (3 days) | 35% (22/63) | 0.67 (0.11–11.11) |
Unknown | - | 3.59 (0 – 41.03) |